Targeting mitochondria to revolutionize medical treatments

From a laboratory at the University of Geneva, MPC Therapeutics harnesses the potential of mitochondria to revolutionize medical treatments for diseases such as cancer and Alzheimer's. The story of a resounding scientific discovery that led to an innovative biotech start-up.

Read the article

Subscribe now

Our monthly newsletter, a selection of the best of innovation in Western Switzerland's Academia.

Your email address is only used to send you our newsletter and information about our activities. You can unsubscribe any time using the link included in each of our emails.